ConductScience.org, home

Paper36908749

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.

Giersch K and 13 others. JHEP Rep, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment. Papers, record 36908749. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908749

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.
PubMed
Journal
JHEP Rep
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2023-03-14
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giersch KKatja
2Perez-Gonzalez PPaulina
3Hendricks LLennart
4Goldmann NNora
5Kolbe JJonathan
6Hermanussen LLennart
7Bockmann JHJan-Hendrick
8Volz TTassilo
9Volmari AAnnika
10Allweiss LLena
11Petersen JJoerg
12Glebe DDieter
13Lütgehetmann MMarc
14Dandri MMaura

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132000689High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.BMC Gastroenterol2020https://conductscience.org/library/papers/32000689PubMed
216903225Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?Curr Top Microbiol Immunol2006https://conductscience.org/library/papers/16903225PubMed
325795587Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.J Hepatol2015https://conductscience.org/library/papers/25795587PubMed
433484770The changing context of hepatitis D.J Hepatol2021https://conductscience.org/library/papers/33484770PubMed
528623307Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.Sci Rep2017https://conductscience.org/library/papers/28623307PubMed
635850738The hepatitis delta virus and chronic hepatitis D.J Hepatol2022https://conductscience.org/library/papers/35850738PubMed
732634548Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.J Hepatol2020https://conductscience.org/library/papers/32634548PubMed
821811602Interferon impedes an early step of hepatitis delta virus infection.PLoS One2011https://conductscience.org/library/papers/21811602PubMed
933509930Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo.Gut2022https://conductscience.org/library/papers/33509930PubMed
1032077599New epidemiology of hepatitis delta.Liver Int2020https://conductscience.org/library/papers/32077599PubMed
1116903222Post-translational modification of delta antigen of hepatitis D virus.Curr Top Microbiol Immunol2006https://conductscience.org/library/papers/16903222PubMed
128415646A genotype of hepatitis D virus that occurs in northern South America.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8415646PubMed
1324623409Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.J Virol2014https://conductscience.org/library/papers/24623409PubMed
148189544The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus.J Virol1994https://conductscience.org/library/papers/8189544PubMed
1534305837Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.Front Microbiol2021https://conductscience.org/library/papers/34305837PubMed
1633845061Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.J Hepatol2021https://conductscience.org/library/papers/33845061PubMed
1731371507Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31371507PubMed
1834019142Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition.Semin Immunopathol2021https://conductscience.org/library/papers/34019142PubMed
193627276Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.Nature1987https://conductscience.org/library/papers/3627276PubMed
2029217749Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo.Gut2019https://conductscience.org/library/papers/29217749PubMed

See all 42 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42842305Sensitive reverse transcription-digital droplet PCR-based discrimination of hepatitis delta virus RNAs reveals differential effects of interferon-α on viral RNA species.J Gen Virol2026https://conductscience.org/library/papers/42842305PubMed
41922429Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus.Sci Rep2026https://conductscience.org/library/papers/41922429PubMed
40872814Updates on Recent Advancements in Hepatitis D Virus Treatment.Viruses2025https://conductscience.org/library/papers/40872814PubMed
40872338Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy.Pathogens2025https://conductscience.org/library/papers/40872338PubMed
39904973Liver diseases: epidemiology, causes, trends and predictions.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39904973PubMed
38793622Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.Viruses2024https://conductscience.org/library/papers/38793622PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36908749

GET https://conductscience.org/api/papers/v1/36908749/references?page=2